In an age of increasingly bespoke healthcare, Elizabeth Philp has become a significant force of innovation, especially in the fast-evolving field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the forefront of a push to make tailor-made medications more accessible, questioning the standard one-size-fits-all approach